How many ketamine treatments for depression ?

Ketamine treatments for depression vary in frequency and duration. Ketamine infusions administered intravenously 1 to 3 times per week are considered the quickest and most effective treatment for depression, suitable for both unipolar and bipolar depressive episodes.

Ketamine has shown rapid and robust antidepressant effects within hours of administration, with an (S)-ketamine nasal spray approved for use in treatment-resistant depression in the US and Europe. Studies suggest that ketamine infusions significantly decrease depression severity ratings in the short term, but evidence on long-term effects is lacking.

Ketamine is also being explored as an experimental treatment for bipolar depression, with limitations including short-lived effects and uncertainties about long-term benefits and safety . Overall, the frequency and duration of ketamine treatments for depression depend on the individual’s response and the specific treatment protocol being followed.

Ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, has been investigated for its rapid antidepressant effects in patients with treatment-resistant depression. The number of treatments and their efficacy are of particular interest in the clinical management of depression.

Key Insights from Research Papers

• Ketamine produces a rapid antidepressant effect, but the benefit is transient, with the most significant effects observed within 24 hours after administration; repeated doses are required to maintain efficacy.

• Twice-weekly and thrice-weekly dosing regimens of intravenous ketamine have been shown to maintain antidepressant effects over a 15-day period.

• Single administrations of ketamine have been associated with higher rates of clinical remission and response at various time points post-treatment, including 24 hours, 3 days, and 7 days.

• Subcutaneous administration of ketamine in older patients suggests that repeated treatments may be more effective in inducing or prolonging remission than a single treatment.

• Oral ketamine has been reported to improve depressive symptoms with varying dosages and frequencies, from daily to monthly, indicating potential for antidepressant effects, although more research is needed.

• Repeated ketamine infusions, up to six sessions, have been associated with a sustained antidepressant effect, with a median time to relapse of 18 days post-treatment among responders.

• A comparison of ketamine infusions with electroconvulsive therapy (ECT) showed that ketamine, despite being inferior to ECT, can be a valuable treatment for unipolar depression.

• Lower infusion rates of ketamine have demonstrated similar efficacy and excellent tolerability, suggesting that serial infusions are more effective than a single infusion.

• Up to six ketamine infusions have been safely administered in a clinical setting, with a response rate comparable to that found in randomized controlled trials (RCTs) of single doses.

Conclusion

The research indicates that ketamine has a rapid but transient antidepressant effect in treatment-resistant depression. Multiple treatments, ranging from twice-weekly to thrice-weekly regimens, are necessary to sustain the antidepressant benefits. The optimal number of treatments varies, with some studies suggesting up to six infusions may be required to achieve and maintain response. The frequency and dosage of ketamine treatments can be adjusted based on individual patient response and tolerability.

Source: